AU Stock MarketDetailed Quotes
MAP Microba Life Sciences Ltd
- 0.170
- +0.010+6.25%
20min DelayMarket Closed Nov 22 16:00 AET
76.13MMarket Cap-3469P/E (Static)
0.170High0.167Low2.72KVolume0.167Open0.160Pre Close455.00Turnover0.22552wk High0.00%Turnover Ratio447.85MShares0.14552wk Low-0.049EPS TTM31.05MFloat Cap0.450Historical HighLossP/E (Static)182.63MShs Float0.135Historical Low-0.049EPS LYR1.88%Amplitude--Dividend TTM1.85P/B1Lot Size--Div YieldTTM
Microba Life Sciences Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|
| Operating cash flow (direct method) | |||
| Cash income from operating activities | 107.11%18.83M | 22.73%9.09M | 7.41M |
| Revenue from customers | 96.25%12.48M | 37.89%6.36M | --4.61M |
| Income from government grants | 130.73%6.3M | -2.39%2.73M | --2.8M |
| Other cash income from operating activities | 1,571.85%51.54K | --3.08K | ---- |
| Cash paid | -58.84%-35.3M | -24.56%-22.22M | -17.84M |
| Payments to suppliers for goods and services | -58.84%-35.3M | -24.56%-22.22M | ---17.84M |
| Direct interest paid | -14.58%-69.22K | -9.27%-60.41K | ---55.29K |
| Direct interest received | 25.66%1M | 1,513.65%799.58K | --49.55K |
| Direct tax refund paid | -13,887.05%-31.33K | 97.57%-224 | ---9.23K |
| Operating cash flow | -25.60%-15.57M | -18.61%-12.39M | ---10.45M |
| Investing cash flow | |||
| Cash flow from continuing investing activities | -365.16%-13.95M | -73.11%-3M | -1.73M |
| Net PPE purchase and sale | -170.20%-1.49M | 66.17%-550.46K | ---1.63M |
| Net intangibles purchas and sale | -16.30%-2.89M | -950.44%-2.49M | ---236.7K |
| Net business purchase and sale | ---9.57M | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---154.13K |
| Net other investing changes | ---- | -86.67%38.09K | --285.79K |
| Cash from discontinued investing activities | |||
| Investing cash flow | -365.16%-13.95M | -73.11%-3M | ---1.73M |
| Financing cash flow | |||
| Cash flow from continuing financing activities | 10.25%18.39M | -42.89%16.68M | 29.22M |
| Net issuance payments of debt | 1,222.32%59.9K | -102.65%-5.34K | --201.59K |
| Net common stock issuance | 10.80%19.1M | -41.26%17.24M | --29.35M |
| Net other financing activities | -39.66%-765.09K | -65.59%-547.84K | ---330.84K |
| Cash from discontinued financing activities | |||
| Financing cash flow | 10.25%18.39M | -42.89%16.68M | --29.22M |
| Net cash flow | |||
| Beginning cash position | 4.78%32.04M | 135.62%30.58M | --12.98M |
| Current changes in cash | -960.94%-11.12M | -92.42%1.29M | --17.03M |
| Effect of exchange rate changes | -118.96%-32.49K | -69.80%171.36K | --567.43K |
| End cash Position | -34.81%20.89M | 4.78%32.04M | --30.58M |
| Free cash from | -29.26%-19.95M | -25.23%-15.43M | ---12.32M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data